186 related articles for article (PubMed ID: 17369843)
1. RB1 and TP53 pathways in radiation-induced sarcomas.
Gonin-Laurent N; Hadj-Hamou NS; Vogt N; Houdayer C; Gauthiers-Villars M; Dehainault C; Sastre-Garau X; Chevillard S; Malfoy B
Oncogene; 2007 Sep; 26(41):6106-12. PubMed ID: 17369843
[TBL] [Abstract][Full Text] [Related]
2. Specific TP53 mutation pattern in radiation-induced sarcomas.
Gonin-Laurent N; Gibaud A; Huygue M; Lefèvre SH; Le Bras M; Chauveinc L; Sastre-Garau X; Doz F; Lumbroso L; Chevillard S; Malfoy B
Carcinogenesis; 2006 Jun; 27(6):1266-72. PubMed ID: 16492679
[TBL] [Abstract][Full Text] [Related]
3. Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.
Markl ID; Jones PA
Cancer Res; 1998 Dec; 58(23):5348-53. PubMed ID: 9850064
[TBL] [Abstract][Full Text] [Related]
4. Genome instability in secondary solid tumors developing after radiotherapy of bilateral retinoblastoma.
Lefèvre SH; Vogt N; Dutrillaux AM; Chauveinc L; Stoppa-Lyonnet D; Doz F; Desjardins L; Dutrillaux B; Chevillard S; Malfoy B
Oncogene; 2001 Dec; 20(56):8092-9. PubMed ID: 11781822
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
[TBL] [Abstract][Full Text] [Related]
8. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
[TBL] [Abstract][Full Text] [Related]
9. Role of transgenic mice in identification and characterization of tumour suppressor genes.
Sharan SK; Bradley A
Cancer Surv; 1995; 25():143-59. PubMed ID: 8718516
[TBL] [Abstract][Full Text] [Related]
10. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
[TBL] [Abstract][Full Text] [Related]
11. The nuclear oncoproteins: RB and p53.
Cowell JK
Semin Cancer Biol; 1990 Dec; 1(6):437-46. PubMed ID: 2151736
[TBL] [Abstract][Full Text] [Related]
12. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis.
Kemp CJ; Wheldon T; Balmain A
Nat Genet; 1994 Sep; 8(1):66-9. PubMed ID: 7987394
[TBL] [Abstract][Full Text] [Related]
13. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a metastasizing testicular mixed gonadal stromal tumor with osteosarcoma components suggests that a malignant tumor with the histology of osteosarcoma may develop without primary involvement of RB1 and TP53.
Reuvekamp PT; Stulp RP; Schraffordt Koops H; Oosterhuis JW; Scheffer H; Buys CH
Cancer Res; 1992 Dec; 52(23):6705-7. PubMed ID: 1423318
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced effects on gene expression: an in vivo study on breast cancer.
Helland A; Johnsen H; Frøyland C; Landmark HB; Saetersdal AB; Holmen MM; Gjertsen T; Nesland JM; Ottestad W; Jeffrey SS; Ottestad LO; Rodningen OK; Sherlock G; Børresen-Dale AL
Radiother Oncol; 2006 Aug; 80(2):230-5. PubMed ID: 16890317
[TBL] [Abstract][Full Text] [Related]
16. [Genomic retinoblastoma perspectives: implications of tumor supressor gene RB1].
Rodríguez-Cruz M; del Prado M; Salcedo M
Rev Invest Clin; 2005; 57(4):572-81. PubMed ID: 16315642
[TBL] [Abstract][Full Text] [Related]
17. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation.
Henriksen J; Aagesen TH; Maelandsmo GM; Lothe RA; Myklebost O; Forus A
Oncogene; 2003 Aug; 22(34):5358-61. PubMed ID: 12917637
[TBL] [Abstract][Full Text] [Related]
18. Contribution of p53, p63, and p73 to the developmental diseases and cancer.
Tomkova K; Tomka M; Zajac V
Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649
[TBL] [Abstract][Full Text] [Related]
19. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
[TBL] [Abstract][Full Text] [Related]
20. TP53 overexpression in radiation-induced osteosarcoma of the rabbit mandible.
Buchholz TA; McCabe K; Cobb J; Haroff H; Prestidge BR; Ehler WJ
Radiat Res; 1999 Mar; 151(3):278-82. PubMed ID: 10073665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
